Bill Humphries joined Merz, Inc. (affiliate of Merz Pharma Group), as President and Chief Executive Officer of its North American business in March of 2012. He is a member of the Merz Pharma Board and the Chairman of the Merz, Inc. Board of Directors.
As Chief Executive Officer, Bill develops and implements overall strategies, manages operations, evaluates financial growth and enhances the ethical culture of the company. Bill is responsible for the continued and accelerated growth of the Aesthetics, Dermatology, OTC/OTX and Neuroscience businesses within North America. Through expansion, Bill hopes to capitalize on innovation and trends that impact the four business specialties and to focus on product diversification; Bill believes that the North American business is in a position to use its competitive capabilities in order to become a leader in every segment that the company serves.
Bill has more than 29 years of experience in the specialty pharmaceutical industry, with more than 26 of those years focused on the commercialization of products in medical dermatology and aesthetics. Bill earned a Master’s degree in Business Administration from Pepperdine University in Malibu, California. He completed his undergraduate studies at Bucknell University in Lewisburg, Pennsylvania, earning a Bachelor of Arts degree.